ArticleBlood advances2024

Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas.

Navika D Shukla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.